Theriva Biologics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Theriva Biologics, Inc. (TOVX) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 27.83 million shares for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-08-11
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-12-31 was 16.18M shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-09-30 was 0.00 shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2024-12-31 was 0.00 shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2023-03-31 was 0.00 shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 1.94M shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2019 was 0.00 shares, a 100.00% decline from fiscal 2018.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 18.00M shares.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 0.00 shares, a 100.00% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 16.18M shares derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-11 | 16.18M shares derived: sum of 2 quarters · filed 2026-08-11 | 27.83M shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 11.65M shares 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 11.65M shares 10-Q · filed 2025-08-11 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 1.94M shares 10-K · filed 2026-03-12 | ||
| 2024-09-30 | 1.94M shares 10-Q · filed 2024-11-12 | |||
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-05-11 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 0.00 shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 | |||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 0.00 shares 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-05 | |||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-10 | 0.00 shares 10-Q · filed 2020-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 0.00 shares 10-Q · filed 2020-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-04 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-04 | 0.00 shares derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-04 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-04 | 0.00 shares 10-K · filed 2021-03-04 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-04 | 0.00 shares 10-Q · filed 2019-11-04 | 18.00M shares derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | 18.00M shares derived: sum of 3 quarters · filed 2020-02-20 | 17.98M shares derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-08 | 18.00M shares derived: sum of 2 quarters · filed 2020-02-20 | 17.98M shares derived: sum of 3 quarters · filed 2020-02-20 | 17.98M shares derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-12-31 | 18.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 17.98M shares derived: sum of 2 quarters · filed 2020-02-20 | 17.98M shares derived: sum of 3 quarters · filed 2020-02-20 | 18.00M shares 10-K · filed 2020-02-20 |
| 2018-09-30 | -24.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -24.29K shares derived: sum of 2 quarters · filed 2018-11-08 | 714.00 shares 10-Q · filed 2018-11-08 | 714.00 shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 25.00K shares 10-Q · filed 2018-08-08 | 25.00K shares derived: sum of 3 quarters · filed 2019-02-27 | 25.00K shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | 25.00K shares 10-Q · filed 2018-05-08 | 25.00K shares derived: sum of 2 quarters · filed 2019-02-27 | 25.00K shares derived: sum of 3 quarters · filed 2019-02-27 | 25.00K shares derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2019-02-27 | 0.00 shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-01 | 0.00 shares 10-Q · filed 2017-11-01 | 50.00M shares derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 0.00 shares 10-Q · filed 2017-08-03 | 50.00M shares derived: sum of 3 quarters · filed 2018-02-22 | 50.00M shares derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-04 | 50.00M shares derived: sum of 2 quarters · filed 2018-02-22 | 50.00M shares derived: sum of 3 quarters · filed 2018-02-22 | 50.00M shares derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-12-31 | 50.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | 50.00M shares derived: sum of 2 quarters · filed 2018-02-22 | 50.00M shares derived: sum of 3 quarters · filed 2018-02-22 | 50.00M shares 10-K · filed 2018-02-22 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-01 | 0.00 shares 10-Q · filed 2016-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-02 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 0.00 shares 10-Q · filed 2016-08-03 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-02 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-02 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-02 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-02 | 0.00 shares derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-02 | 0.00 shares derived: sum of 3 quarters · filed 2017-03-02 | 0.00 shares 10-K · filed 2017-03-02 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2015-11-05 | 0.00 shares 10-Q · filed 2015-11-05 | 7.03M shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | 7.03M shares derived: sum of 3 quarters · filed 2016-03-10 | 7.03M shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 7.03M shares derived: sum of 2 quarters · filed 2016-03-10 | 7.03M shares derived: sum of 3 quarters · filed 2016-03-10 | 7.03M shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-12-31 | 7.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 7.03M shares derived: sum of 2 quarters · filed 2016-03-10 | 7.03M shares derived: sum of 3 quarters · filed 2016-03-10 | 7.03M shares 10-K · filed 2016-03-10 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-14 | 0.00 shares 10-Q · filed 2014-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | 0.00 shares 10-Q · filed 2014-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-10 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-10 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-10 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-10 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-10 | 0.00 shares 10-K · filed 2016-03-10 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-14 | 0.00 shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 0.00 shares 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | 985.86K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |